Breadcrumb Home Articles Search Articles Search Search Search Filter Results Categories Media (39) News (15) Newsletters (18) Topics Reset Search Winter 2023 Newsletter Investigators announced positive results from a phase 3 study of the amyloid-lowering monoclonal antibody lecanemab.... February 10, 2023 1 min read FDA Approved the New Alzheimer's Drug, Marketed as Leqembi January 06, 2023 1 min read Axonal Swelling in Alzheimer’s Disease and New Tests May Improve the Certainty of Alzheimer’s Diagnosis December 01, 2022 1 min read The Risk and Benefits of the New Alzheimer’s Drug November 30, 2022 1 min read Can the New Alzheimer’s Drug Slow the Progression of the Disease? November 30, 2022 1 min read Eisai’s Approach To the New Alzheimer’s Drug November 29, 2022 1 min read L.A. Founder Chapter of Achievement Rewards for College Scientist (ARCS) 62nd Annual Scholar Recognition Luncheon November 11, 2022 1 min read Updates on Lecanemab October 28, 2022 1 min read John Douglas French Alzheimer’s Foundation Endowed Chair Award October 27, 2022 1 min read Autumn 2022 Newsletter Scientists have discovered that amyloid deposits are made up of the protein amyloid-beta and NFTs are composed of tau.... September 22, 2022 1 min read Pagination Previous page Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Next page
